Pathogenic old world arenaviruses inhibit TLR2/Mal-dependent proinflammatory cytokines in vitro

Journal of Virology

Volumn 86, Issue 13, 2012, Pages 7216-7226

  Hayes, Melissa W ^a   Carrion, Ricardo ^b   Nunneley, Jerritt ^b   Medvedev, Andrei E ^a   Salvato, Maria S ^a   Lukashevich, Igor S ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^c University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CD14 ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 16; INTERLEUKIN 8; MYD88 ADAPTOR LIKE PROTEIN; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARENAVIRUS; ARENAVIRUS INFECTION; ARTICLE; CELL ASSAY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; LASSA VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MACROPHAGE; MICROBIAL ACTIVITY; MOLECULAR CLONING; MOPEIA VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; STRAIN DIFFERENCE; SUPERINFECTION; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALIA; ARENAVIRUS; LASSA VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MACACA MULATTA; MOPEIA VIRUS; OLD WORLD ARENAVIRUSES;

EID: 84864143308     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06508-11     Document Type: Article

References (65)

1. Akashi-Takamura S, Miyake K. 2008. TLR accessory molecules. Curr. Opin. Immunol. 20:420-425.
2. Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499 -511.
3. Anonymous. 2008. Lymphocytic choriomeningitis virus transmitted through solid organ transplantation-Massachusetts, 2008. MMWR Morb. Mortal. Wkly. Rep. 57:799-801.
4. Asper M, et al. 2004. Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus. J. Virol. 78:3162-3169.
5. Baize S, et al. 2006. Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages. Microbes Infect. 8:1194 -1202.
6. Baize S, et al. 2004. Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J. Immunol. 172: 2861-2869.
7. Baize S, et al. 2009. Early and strong immune responses are associated with control of viral replication and recovery in Lassa virus-infected cynomolgus monkeys. J. Virol. 83:5890 -5903.
8. Barbalat R, Lau L, Locksley RM, Barton GM. 2009. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat. Immunol. 10:1200 -1207.
9. Bergthaler A, et al. 2010. Viral replicative capacity is the primary determinant of lymphocytic choriomeningitis virus persistence and immunosuppression. Proc. Natl. Acad. Sci. U. S. A. 107:21641-21646.
10. Bonthius DJ, Perlman S. 2007. Congenital viral infections of the brain: lessons learned from lymphocytic choriomeningitis virus in the neonatal rat. PLoS Pathog. 3:e149. doi:10.1371/journal.ppat.0030149.
11. Bonthius DJ, et al. 2007. Congenital lymphocytic choriomeningitis virus infection: spectrum of disease. Ann. Neurol. 62:347-355.
12. Briese T, et al. 2009. Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathog. 4:e1000455.
13. Cao W, et al. 1998. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 282: 2079-2081.
14. Carnec X, et al. 2011. Lassa virus nucleoprotein mutants generated by reverse genetics induce robust type I IFN response in human dendritic cells and macrophages. J. Virol. 85:12093-12097.
15. Carrion R, Jr, et al. 2007. Lassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissues. J. Virol. 81:6482- 6490.
16. Cuevas CD, Lavanya M, Wang E, Ross SR. 2011. Junin virus infects mouse cells and induces innate immune responses. J. Virol. 85:11058- 11068.
17. Djavani M, Lukashevich IS, Salvato MS. 1998. Sequence comparison of the large genomic RNA segments of two strains of lymphocytic choriomeningitis virus differing in pathogenic potential for guinea pigs. Virus Genes 17:151-155.
18. Djavani MM, et al. 2007. Early blood profiles of virus infection in a monkey model for Lassa fever. J. Virol. 81:7960 -7973.
19. Fennewald SM, Aronson JF, Zhang L, Herzog NK. 2002. Alterations in NF-kappaB and RBP-Jkappa by arenavirus infection of macrophages in vitro and in vivo. J. Virol. 76:1154 -1162.
20. Fichet-Calvet E, Rogers DJ. 2009. Risk maps of Lassa fever in West Africa. PLoS Negl. Trop. Dis. 3:e388.
21. Fischer SA, et al. 2006. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N. Engl. J. Med. 354:2235-2249.
22. Flatz L, et al. 2010. T cell-dependence of Lassa fever pathogenesis. PLoS Pathog. 6:e1000836. doi:10.1371/journal.ppat.1000836.
23. Geisbert TW, Jahrling PB. 2004. Exotic emerging viral diseases: progress and challenges. Nat. Med. 10:S110 -S121.
24. Glushakova SE, et al. 1990. Lysosomotropic agents inhibit the penetration of arenaviruses into a culture of BHK-21 and Vero cells. Vopr. Virusol. 35:146 -150.
25. Gowen BB, Holbrook MR. 2008. Animal models of highly pathogenic RNA viral infections: hemorrhagic fever viruses. Antiviral Res. 78:79 -90.
26. Groseth A, et al. 2011. Tacaribe virus but not Junin virus infection induces cytokine release from primary human monocytes and macrophages. PLoS Negl. Trop. Dis. 5:e1137.
27. Hensley LE, et al. 2011. Pathogenesis of Lassa fever in cynomolgus macaques. Virol. J. 8:205.
28. Imperiali M, Spörri R, Hewitt J, Oxenius A. 2008. Post-translational modification of α-dystroglycan is not critical for lymphocytic choriomeningitis virus receptor function in vivo. J. Gen. Virol. 89:2713-2722.
29. Ishii A, et al. 2011. Novel arenavirus, Zambia. Emerg. Infect. Dis. 17: 1921-1924.
30. Jahrling PB, Peters CJ. 1992. Lymphocytic choriomeningitis virus. A neglected pathogen of man. Arch. Pathol. Lab. Med. 116:486-488.
31. Jung A, et al. 2008. Lymphocytoid choriomeningitis virus activates plasmacytoid dendritic cells and induces a cytotoxic T-cell response via MyD88. J. Virol. 82:196 -206.
32. Kunz S. 2009. Receptor binding and cell entry of Old World arenaviruses reveal novel aspects of virus-host interaction. Virology 387:245-249.
33. Kunz S, et al. 2005. Posttranslational modification of alpha-dystroglycan, the cellular receptor for arenaviruses, by the glycosyltransferase LARGE is critical for virus binding. J. Virol. 79:14282-14296.
34. Lukashevich IS. 1992. Generation of reassortants between African arenaviruses. Virology 188:600-605.
35. Lukashevich IS, et al. 2003. Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation. J. Virol. 77:1727-1737.
36. Lukashevich IS, et al. 2004. LCMV-mediated hepatitis in rhesus macaques: WE but not ARM strain activates hepatocytes and induces liver regeneration. Arch. Virol. 149:2319 -2336.
37. Lukashevich IS, et al. 2002. Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus. J. Med. Virol. 67:171-186.
38. Lukashevich IS, et al. 1999. Lassa and Mopeia virus replication in human monocytes/macrophages and in endothelial cells: different effects on IL-8 and TNF-alpha gene expression. J. Med. Virol. 59:552-560.
39. Mahanty S, et al. 2001. Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever. J. Infect. Dis. 183:1713-1721.
40. Mahanty S, et al. 2003. Impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J. Immunol. 170:2797-2801.
41. Martinez-Sobrido L, Giannakas P, Cubitt B, Garcia-Sastre A, de la Torre JC. 2007. Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J. Virol. 81:12696 -12703.
42. Martinez-Sobrido L, Zuniga EI, Rosario D, Garcia-Sastre A, de la Torre JC. 2006. Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 80:9192-9199.
43. McCormick JB, Fisher-Hoch SP. 2002. Lassa fever. Curr. Top. Microbiol. Immunol. 262:75-109.
44. McCormick JB, et al. 1986. Lassa fever. Effective therapy with ribavirin. N. Engl. J. Med. 314:20 -26.
45. Medzhitov R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135-145.
46. Moraz M-L, Kunz S. 2011. Pathogenesis of arenavirus hemorrhagic fevers. Expert Rev. Anti Infect. Ther. 9:49 -59.
47. Murawski MR, et al. 2009. Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J. Virol. 83:1492-1500.
48. Oldstone MBA, Campbell KP. 2011. Decoding arenavirus pathogenesis: essential roles for alpha-dystroglycan-virus interactions and the immune response. Virology 411:170 -179.
49. Pannetier D, et al. 2011. Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus. J. Virol. 85:8293- 8306.
50. Quevedo-Diaz M, et al. 2010. Involvement of TLR2 and TLR4 in cell responses to Rickettsia akari. J. Leukoc. Biol. 88:675- 685.
51. Salvato M, Borrow P, Shimomaye E, Oldstone MB. 1991. Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence. J. Virol. 65:1863-1869.
52. Salvato MS, et al. 2012. Family Arenaviridae, p 715-723. In King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ (ed), Virus taxonomy, classification and nomenclature of viruses. Ninth Report of the International Committee on Taxonomy of Viruses. Elsevier Academic Press, Inc, San Diego, CA.
53. Schildknecht A, Welti S, Geuking MB, Hangartner L, van den Broek M. 2008. Absence of CTL responses to early viral antigens facilitates viral persistence. J. Immunol. 180:3113-3121.
54. Shimojima M, Ströher U, Ebihara H, Feldmann H, Kawaoka Y. 2012. Identification of cell surface molecules involved in dystroglycanindependent Lassa virus cell entry. J. Virol. 86:2067-2078.
55. Simmons DL, Tan S, Tenen DG, Nicholson-Weller A, Seed B. 1989. Monocyte antigen CD14 is a phospholipid anchored membrane protein. Blood 73:284 -289.
56. Sullivan BM, et al. 2011. Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence. Proc. Natl. Acad. Sci. U. S. A. 108:2969 -2974.
57. Takeuchi O, Akira S. 2008. MDA5/RIG-I and virus recognition. Curr. Opin. Immunol. 20:17-22.
58. Tayeh A, Tatard C, Kako-Ouraga S, Duplantier J-M, Dobigny G. 2010. Rodent host cell/Lassa virus interactions: evolution and expression of [alpha]-dystroglycan, LARGE-1 and LARGE-2 genes, with special emphasis on the Mastomys genus. Infect. Genet. Evol. 10:1262-1270.
59. Wilson EB, Brooks DG. 2010. Translating insights from persistent LCMV infection into anti-HIV immunity. Immunol. Res. 48:3-13.
60. Yun NE, et al. 2012. Functional interferon system is required for clearance of Lassa virus. J. Virol. 86:3389 -3392.
61. Zapata J, et al. 2010. Expression of coagulation factor thrombomodulin is increased in cells exposed to Lassa virus, p 291. Abstr. 29th Am. Soc. Virol. Annu. Meet., Bozeman, MT.
62. Zapata JC, et al. 2011. Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever. Antiviral Res. 92:125- 138.
63. Zhou S, et al. 2010. Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus. J. Virol. 84:9452-9462.
64. Zhou S, et al. 2009. MyD88 intrinsically regulates CD4 T-cell responses. J. Virol. 83:1625-1634.
65. Zhou S, et al. 2005. MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection. Eur. J. Immunol. 35:822- 830.